Skip to main content
. Author manuscript; available in PMC: 2018 Nov 7.
Published in final edited form as: Surgery. 2018 Mar 12;163(5):1090–1096. doi: 10.1016/j.surg.2017.11.027

Table 4.

Clinically Important severe complications greater than or equal to Clavien grade 3a in the neoadjuvant SBRT and neoadjuvant CRT groups.

Complication type Neoadjuvant
SBRT n = 14 (23.0% of the total of 61 patients)
Neoadjuvant
CRT n = 30 (28.0% of the total of 107 patients)
P
Reoperation 3 (5%) 8 (8%) .519
Postoperative
    pancreatic fistula
    requiring drain
    placement
3 (5%) 6 (6%) .849
Clinically important
    bleeding event
4 (7%) 4 (4%) .409
Sepsis with organ
    dysfunction requiring
    critical care
3 (5%) 8 (8%) .519
Respiratory failure
    requiring intubation
2 (3%) 7 (7%) .366
Other invasive
    procedure
3 (5 %) 4 (3.4%) .713
Death 1 (2%) 3 (3%) .634